The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related ...

WeightWatchers said on Tuesday it would offer compounded form of Novo Nordisk's popular obesity drug Wegovy as part of its ...

Shares of Weight Watchers parent company WW International (WW) rose nearly 40% after the company announced plans to begin ...

High demand has created a market for compounded versions of the drug best known as Ozemic or Wegovy, but doctors and the FDA ...

Shares of WeightWatchers (WW) are climbing after the company announced a new GLP-1 medication starting at $129 as it seeks to ...

The embattled diet brand said it is adding a compounded weight-loss drug in accordance with FDA rules and manufacturing ...

WeightWatchers (WW) announced Tuesday that it is now offering off-brand weight loss drugs for one of the cheapest prices in ...

WW International (NASDAQ:WW), more commonly known as WeightWatchers, will now offer compounded semaglutide to its ...

Weight Watchers has revealed a major shake-up to the way customers will experience their program in Australia.

WeightWatchers said on Tuesday it would offer a compounded version of Novo Nordisk's popular obesity drug Wegovy as part of ...

WeightWatchers stock rises after the company announces compounded semaglutide offerings, addressing GLP-1 shortages while ...

With the addition of compounded semaglutide [GLP-1], we are expanding our offering to include a clinical weight management ...